Roskamp Institute Media Coverage

Share this postShare on Google+Share on LinkedInShare on FacebookTweet about this on TwitterEmail this to someone

Following is a breakdown of some additional media coverage about the Roskamp Institute’s recent announcement of a new Phase III MS Study to Evaluate the Efficacy and Safety of FTY720.  Following is some of the pickups.

alzheimers michael mullan